Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.90%
1,104.10
-10.04
-0.90%
—1,114.141,119.391,121.191,103.52——
SIXC
Communications
SIXC
Communications
SIXC
+0.58%
617.12
+3.54
+0.58%
—613.60613.60617.80613.60——
SIXE
Energy
SIXE
Energy
SIXE
-2.72%
1,165.94
-32.62
-2.72%
—1,198.561,188.461,188.461,159.56——
SIXI
Industrials
SIXI
Industrials
SIXI
-0.85%
1,769.24
-15.21
-0.85%
—1,784.451,788.951,792.831,768.41——
SIXM
Financials
SIXM
Financials
SIXM
-0.14%
637.89
-0.90
-0.14%
—638.79638.37641.72634.21——
SIXR
Staples
SIXR
Staples
SIXR
-0.65%
845.03
-5.55
-0.65%
—850.50848.90848.90839.52——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.61%
218.36
-1.33
-0.61%
—219.69219.69219.69216.89——
SIXT
Technology
SIXT
Technology
SIXT
+0.67%
3,447.20
+23.01
+0.67%
—3,424.193,429.183,463.333,412.28——
SIXU
Utilities
SIXU
Utilities
SIXU
-0.90%
917.42
-8.34
-0.90%
—925.76922.77923.99916.10——
SIXV
Health care
SIXV
Health care
SIXV
-0.74%
1,458.59
-10.81
-0.74%
—1,469.401,468.961,473.181,457.86——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0.31%
2,432.02
+7.40
+0.31%
—2,424.622,438.232,446.632,426.97——
SYK:NYSE
Stryker Corp
$296.72
+1.50%
(+4.39) 1D
May 7, 11:59:30 AM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SYK...
Open
$292.96
High
$298.73
Low
$292.48
Mkt. cap
114.13B
Avg. vol.
2.14M
Volume
683.62K
Dividend
1.19%
Quarterly dividend
$0.88
Ex dividend date
Mar 31, 2026
P/E ratio
34.37
52-wk high
$404.87
52-wk low
$289.91
EPS
$8.63
Beta
0.80
Shares outstanding
382.98M
No. of employees
56K
News stories
From sources across the web
Profile
Stryker Corporation is an American multinational medical technologies corporation based in Portage, Michigan, United States. The company's products are used for medical surgery and neurotechnology, which include surgical equipment, patient and caregiver safety technologies, endoscopy systems, and patient handling, emergency medical equipment, and intensive care disposable products, as well as neurosurgical, neurovascular and oral and maxillofacial surgery implant products; and orthopedic surgery, which includes implants used in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. Stryker's products are sold in over 75 countries and are used by 150 million patients annually. In 2024, 75% of the company's revenues came from the United States. The company is ranked 195th on the Fortune 500 and 331st on the Forbes Global 2000. Wikipedia
About Stryker Corp
CEOKevin A. Lobo
Employees56K
Founded1941
HeadquartersKalamazoo, Michigan, United States
SectorMedical device
Websitestryker.com
Last report
Apr 30, 2026
Fiscal Period
Q1 2026
Normalized EPS / Estimate
2.60/ (2.98 est.)USD
-12.86%miss
Revenue / Estimate
6.02B/ (6.33B est.)USD
-4.89%miss
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
6.02B
6.06B
7.17B
6.02B
Cost of goods sold
2.11B
2.12B
2.49B
2.19B
Cost of revenue
2.11B
2.12B
2.49B
2.19B
Research and development expenses
403.00M
409.00M
388.00M
409.00M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.00B
1.99B
2.15B
2.16B
Operating expense
2.59B
2.58B
2.72B
2.75B
Total operating expenses
4.70B
4.71B
5.22B
4.95B
Operating income
1.32B
1.35B
1.95B
1.07B
Other non operating income
-138.00M
-138.00M
541.00M
-86.00M
EBT including unusual items
1.02B
1.03B
1.70B
850.00M
EBT excluding unusual items
1.23B
1.25B
1.81B
987.00M
Income tax expense
132.00M
170.00M
856.00M
105.00M
Effective tax rate
12.99%
16.52%
50.21%
12.35%
Other operating expenses
-
-
-
-
Net income
884.00M
859.00M
849.00M
745.00M
Net profit margin
14.68%
14.18%
11.84%
12.38%
Earnings per share
3.13
3.19
4.47
2.60
Interest and investment income
24.00M
28.00M
-
-
Interest expense
-
-
-697.00M
-
Net interest expenses
24.00M
28.00M
-697.00M
-
Depreciation and amortization charges
-
-
-
-
EBITDA
1.62B
1.66B
2.27B
1.37B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer